Clinical Trial

BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures

Study acronym: FIAS
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine safety signals and demonstrate seizure reduction in adults with FIAS treated with BIS-001ER as an add-on therapy in an in-patient and out-patient study design.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2018-03-21; most recent amendment 2022-08-29.
Status change: Recruiting → Active, Not Recruiting 2021-04-13
Trial Details
NCT Number NCT03474770
Lead Sponsor Supernus Pharmaceuticals, Inc.
Conditions Focal Impaired Awareness Seizures
Enrollment 16 participants
Start Date 2018-04-10
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2022-08-30